Arovella Therapeutics Financial Health

Short Term Liabilities: ALA's short term assets (A$6.6M) exceed its short term liabilities (A$1.5M).

Long Term Liabilities: ALA's short term assets (A$6.6M) exceed its long term liabilities (A$86.8K).

Debt Level: ALA is debt free.

Reducing Debt: ALA has no debt compared to 5 years ago when its debt to equity ratio was 10.7%.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALA has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ALA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.7% each year

• Healthy companies in the Pharmaceuticals & Biotech industry.